- Home
- VTEX vs RZLT Comparison
VTEX vs RZLT Comparison
Compare VTEX & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTEX
- RZLT
- Stock Information
- Founded
- VTEX 1999
- RZLT 2010
- Country
- VTEX Cayman Islands
- RZLT United States
- Employees
- VTEX N/A
- RZLT N/A
- Industry
- VTEX Computer Software: Prepackaged Software
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- VTEX Technology
- RZLT Health Care
- Exchange
- VTEX Nasdaq
- RZLT Nasdaq
- Market Cap
- VTEX 757.0M
- RZLT 713.4M
- IPO Year
- VTEX 2021
- RZLT N/A
- Fundamental
- Price
- VTEX $4.21
- RZLT $8.23
- Analyst Decision
- VTEX Strong Buy
- RZLT Strong Buy
- Analyst Count
- VTEX 4
- RZLT 6
- Target Price
- VTEX $7.63
- RZLT $14.50
- AVG Volume (30 Days)
- VTEX 1.1M
- RZLT 1.6M
- Earning Date
- VTEX 11-04-2025
- RZLT 11-06-2025
- Dividend Yield
- VTEX N/A
- RZLT N/A
- EPS Growth
- VTEX 48.79
- RZLT N/A
- EPS
- VTEX 0.05
- RZLT N/A
- Revenue
- VTEX $230,497,000.00
- RZLT N/A
- Revenue This Year
- VTEX $10.08
- RZLT N/A
- Revenue Next Year
- VTEX $14.18
- RZLT N/A
- P/E Ratio
- VTEX $79.79
- RZLT N/A
- Revenue Growth
- VTEX 4.53
- RZLT N/A
- 52 Week Low
- VTEX $3.92
- RZLT $2.22
- 52 Week High
- VTEX $7.31
- RZLT $9.72
- Technical
- Relative Strength Index (RSI)
- VTEX 40.77
- RZLT 47.72
- Support Level
- VTEX $4.27
- RZLT $8.65
- Resistance Level
- VTEX $4.62
- RZLT $9.29
- Average True Range (ATR)
- VTEX 0.15
- RZLT 0.49
- MACD
- VTEX 0.01
- RZLT -0.16
- Stochastic Oscillator
- VTEX 6.82
- RZLT 8.77
About VTEX VTEX
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.